Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L O Arthur

Showing results (81-90 of 119) with videos related to

Pageof 12
Sort By:
AIDS Research and Human Retroviruses|May 1, 1997
Wild-type and mutant HIV type 1 nucleocapsid proteins increase the proportion of long cDNA transcripts by viral reverse transcriptaseJ E Drummond, P Mounts, R J Gorelick, et al.
Journal of Virology|May 1, 1995
Macaques immunized with HLA-DR are protected from challenge with simian immunodeficiency virusL O Arthur, J W Bess, R G Urban, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1986
Octapeptides deduced from the neuropeptide receptor-like pattern of antigen T4 in brain potently inhibit human immunodeficiency virus receptor binding and T-cell infectivityC B Pert, J M Hill, M R Ruff, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1986
Human retroviral env and gag polypeptides: serologic assays to measure infectionS B Kanner, C Cheng-Mayer, R B Geffin, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1988
Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120J R Rusche, K Javaherian, C McDanal, et al.
Journal of Virology|July 1, 1995
Isolation and characterization of a syncytium-inducing, macrophage/T-cell line-tropic human immunodeficiency virus type 1 isolate that readily infects chimpanzee cells in vitro and in vivoR Shibata, M D Hoggan, C Broscius, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1989
HIV-1 and its envelope glycoprotein down-regulate chemotactic ligand receptors and chemotactic function of peripheral blood monocytesS M Wahl, J B Allen, S Gartner, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1989
Vaccine protection against simian immunodeficiency virus infectionR C Desrosiers, M S Wyand, T Kodama, et al.
Archives of Virology|January 1, 1987
Simultaneous isolation of simian foamy virus and HTLV-III/LAV from chimpanzee lymphocytes following HTLV-III or LAV inoculationP L Nara, W G Robey, L O Arthur, et al.
Journal of Virology|April 11, 1992
Gag proteins of the highly replicative MN strain of human immunodeficiency virus type 1: posttranslational modifications, proteolytic processings, and complete amino acid sequencesL E Henderson, M A Bowers, R C Sowder, et al.
Pageof 12

Showing results (81-90 of 119) with videos related to

Sort By:
Pageof 12
AIDS Research and Human Retroviruses|May 1, 1997
Wild-type and mutant HIV type 1 nucleocapsid proteins increase the proportion of long cDNA transcripts by viral reverse transcriptaseJ E Drummond, P Mounts, R J Gorelick, et al.
Journal of Virology|May 1, 1995
Macaques immunized with HLA-DR are protected from challenge with simian immunodeficiency virusL O Arthur, J W Bess, R G Urban, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1986
Octapeptides deduced from the neuropeptide receptor-like pattern of antigen T4 in brain potently inhibit human immunodeficiency virus receptor binding and T-cell infectivityC B Pert, J M Hill, M R Ruff, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1986
Human retroviral env and gag polypeptides: serologic assays to measure infectionS B Kanner, C Cheng-Mayer, R B Geffin, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1988
Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120J R Rusche, K Javaherian, C McDanal, et al.
Journal of Virology|July 1, 1995
Isolation and characterization of a syncytium-inducing, macrophage/T-cell line-tropic human immunodeficiency virus type 1 isolate that readily infects chimpanzee cells in vitro and in vivoR Shibata, M D Hoggan, C Broscius, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1989
HIV-1 and its envelope glycoprotein down-regulate chemotactic ligand receptors and chemotactic function of peripheral blood monocytesS M Wahl, J B Allen, S Gartner, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1989
Vaccine protection against simian immunodeficiency virus infectionR C Desrosiers, M S Wyand, T Kodama, et al.
Archives of Virology|January 1, 1987
Simultaneous isolation of simian foamy virus and HTLV-III/LAV from chimpanzee lymphocytes following HTLV-III or LAV inoculationP L Nara, W G Robey, L O Arthur, et al.
Journal of Virology|April 11, 1992
Gag proteins of the highly replicative MN strain of human immunodeficiency virus type 1: posttranslational modifications, proteolytic processings, and complete amino acid sequencesL E Henderson, M A Bowers, R C Sowder, et al.
Pageof 12